Abstract
Nasal absorption of recombinant human granulocyte colony-stimulating factor (rhG-CSF) was examined in the rat. The relative bioavailability of rhG-CSF for subcutaneous administration was ∼2%, as evaluated from the immunologically active rhG-CSF concentration in rat plasma and the area under the curve (AUC) of the plasma rhG-CSF concentration versus time for 8 hr. Pharmacological availability relative to subcutaneous administration was determined from the increase in total blood leukocyte numbers. The pharmacological availability was 5–10%, determined from the AUC for the increased ratio of total leukocyte numbers versus time for 48 hr; it was slightly dependent on the pH and the osmotic pressure of the dosing solution. Accordingly, the plasma concentration of rhG-CSF did not always reflect its pharmacological effects. Relative bioavailability and pharmacological availability were increased about 23 times and 3 times, respectively, by polyoxyethylene 9-lauryl ether (Laureth-9), but no increase in availability occurred with sodium glycocholate. The increase in total leukocyte numbers was maintained during multiple rhG-CSF dosing, and the addition of Laureth-9 further increased the pharmacological effects of this agent. This study indicates that nasal administration of rhG-CSF is an effective parenteral administration route.
Similar content being viewed by others
REFERENCES
H. Nomura, I. Imazeki, M. Oheda, N. Kubota, M. Tamura, M. Ono, Y. Ueyama, and S. Asano. Purification and characterization of human granulocyte colony-stimulating factor (G-CSF). EMBO J. 5:871–876 (1986).
S. Nagata, M. Tsuchiya, S. Asano, O. Yamamoto, Y. Hirata, N. Kubota, M. Oheda, H. Nomura, and T. Yamazaki. The chromosomal gene structure and two mRNA for human granulocyte colony-stimulating factor. EMBO J. 5:575–581 (1986).
S. Nagata, M. Tsuchiya, S. Asano, Y. Kaziro, T. Yamazaki, O. Yamamoto, Y. Hirata, N. Kubota, M. Oheda, H. Nomura, and M. Ono. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415–418 (1986).
M. Oheda, S. Hase, M. Ono, and T. Ikenaka. Structures of the sugar chains of recombinant human granulocyte-colony-stimulating factor produced by Chinese hamster ovary cells. J. Biochem. 103:544–546 (1988).
S. Kamachi, H. Motojima, M. Oheda, T. Kojima, E. Matsuda, K. Yamamoto, M. Fukushima, M. Ono, K. Watari, and S. Asano. Properties of natural granulocyte colony-stimulating factor (G-CSF). KISO TO RINSHO (The Clinical Report) 25:311–316 (1991) (in Japanese).
Y. W. Chien and S.-F. Chang. Intranasal drug delivery for systemic medications. CRC. Crit. Rev. Ther. Drug Carrier Syst. 4:67–194 (1987).
J. Iida, I. Saiki, C. Ishihara, and I. Azuma. Protective activity of recombinant cytokines against Sendai virus and herpes simplex virus (HSV) infections in mice. Vaccine 7:229–233 (1989).
S. Hirai, T. Yashiki, T. Matsuzawa, and H. Mima. Absorption of drugs from the nasal mucosa of rat. Int. J. Pharm. 7:317–325 (1981).
H. Motojima, T. Kobayashi, M. Shimane, S. Kamachi, and M. Fukushima. Quantitative enzyme immunoassay for human granulocyte colony-stimulating factor (G-CSF). J. Immunol. Methods 118:187–192 (1989).
C. McMartin, L. E. F. Hutchinson, R. Hyde, and G. Peters. Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity. J. Pharm. Sci. 76:535–540 (1987).
S. Hirai, T. Yashiki, and H. Mima. Effect of surfactants on the nasal absorption of insulin in rats. Int. J. Pharm. 9:165–172 (1981).
M. D. Daugherty, H. D. Liggitt, J. G. McCabe, J. A. Moore, and J. S. Patton. Absorption of recombinant methionyl-human growth hormone (Met-hGH) from rat nasal mucosa. Int. J. Pharm. 45:197–206 (1988).
M. D. Dononvan, G. L. Flynn, and G. L. Amidon. The molecular weight dependence on nasal absorption: The effect of absorption enhancers. Pharm. Res. 7:808–815 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Machida, M., Sano, K., Arakawa, M. et al. Absorption of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) from Rat Nasal Mucosa. Pharm Res 10, 1372–1377 (1993). https://doi.org/10.1023/A:1018990318090
Issue Date:
DOI: https://doi.org/10.1023/A:1018990318090